Table 3.
Correlation between gender and antibiotic resistance profile among Gram-positive samples
| Antibiotic | Resistance profile | P-value* | ||
|---|---|---|---|---|
| Sensitive | Intermediate | Resistant | ||
| Linezolid | ||||
|
Male Female |
38 15 |
0 0 |
9 5 |
0.547 |
| Tetracycline | ||||
|
Male Female |
9 3 |
9 0 |
29 17 |
0.079 |
| Chloramphenicol | ||||
|
Male Female |
31 14 |
9 3 |
7 3 |
0.919 |
| Rifampin | ||||
|
Male Female |
25 10 |
2 2 |
20 8 |
0.662 |
| Piperacillin | ||||
|
Male Female |
1 0 |
0 0 |
46 20 |
0.511 |
| Cefoxitin | ||||
|
Male Female |
3 1 |
0 0 |
44 19 |
0.827 |
| Gentamycin | ||||
|
Male Female |
22 8 |
7 4 |
18 8 |
0.828 |
| Ampicillin/Sulbactam | ||||
|
Male Female |
3 1 |
0 0 |
44 19 |
0.827 |
| Levofloxacin | ||||
|
Male Female |
3 1 |
0 0 |
44 19 |
0.827 |
| Ciprofloxacin | ||||
|
Male Female |
25 10 |
3 2 |
19 8 |
0.872 |
| Amoxicillin/Clavulanic | ||||
|
Male Female |
3 1 |
0 0 |
44 19 |
0.827 |
| Vancomycin | ||||
|
Male Female |
3 1 |
0 0 |
44 19 |
0.827 |
*Chi square test; P-value was set to 0.05